SA
RCPI

Scarborough Advisors’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Scarborough Advisors’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$1 – 79
2023
Q2 		$1 Hold
10,000
– – ﹤0.01% 72
2023
Q1 		$1 Buy
+10,000
New +$1 ﹤0.01% 70

Scarborough Advisors's RCPI Position: Q3 2023 in Review

Scarborough Advisors sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2023, closing a stake of 10,000 shares — an estimated $1 sold.

Scarborough Advisors first reported a position in RCPI in Q1 2023 and held it in 2 quarters. The position peaked at $1 in Q2 2023. 0 funds tracked by Wall St. Rank hold RCPI as of Q3 2023.

  • Scarborough Advisors reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2023 after selling out during the quarter.
  • Scarborough Advisors sold 10,000 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2023, an estimated $1.
  • Scarborough Advisors first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q1 2023 and held it in 2 quarters.
  • Scarborough Advisors's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $1 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2023.

Based on Scarborough Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.